Company intelligence / Profile preview
Kapoose Creek Bio
Vancouver, British Columbia, Canadakapoosecreek.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Kapoose Creek Bio has rapidly advanced two potent natural product-derived compounds targeting neurological indications. Both are in late-stage optimization prior to preclinical candidate nomination. The company leverages its proprietary AI-driven unEarth Rx™ platform—now enhanced by Adapsyn’s technology—to accelerate the discovery and development of novel small molecule therapeutics from nature.
- Therapeutic areas
- OncologyPsychiatryNeurologyInfectious Diseases
- Modalities
- small molecules (natural products, fungal-derived compounds)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Adapsyn Bioscience – exclusive license/acquisition of technology and lab assetscollaboration with McMaster University researchers supported by Genome Canada.
Beyond the preview
Go deeper on Kapoose Creek Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kapoose Creek Bio.